Novo Medix Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2020.
2020 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Novo Medix Pharmaceutical Private Limited

Novo Medix Pharmaceutical Private Limited, a active private limited company, was established on 03 January 2020 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85100WB2020PTC235666. Registered under ROC Roc Kolkata Ii. it is unlisted. It has an authorized capital of ₹0.60 M and a paid-up capital of ₹0.60 M.

Employing 20 professional, Its leadership includes Aurobinda Banerjee (Whole-Time Director), Sabir Hossain (Additional Director), Khondaker Nurul Islam (Additional Director). Past directors included Aurobinda Banerjee, Abhijit Basu, Jyotirmoy Roy Karmakar. It holds ₹4.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 191 Debinibas Road, Ground Floor P.O - Motijheel, P.S. Dumdum, Kolkata, West Bengal, 700074.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100WB2020PTC235666

  • Registration Number

    235666

  • Incorporation Date

    03 January 2020

  • Authorized Capital

    ₹0.60 M

  • Paid-Up Capital

    ₹0.60 M

  • ROC Code

    Roc Kolkata Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.60 M
  • Paid Up Capital ₹ 0.60 M
  • Company Age 6 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.00 M
  • Revenue Growth **** -20.68%
  • Profit Growth **** -51.80%
  • Ebitda **** 15732.95%
  • Net Worth 83.86%
  • Total Assets **** 33.33%
Company report

Novo Medix Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Novo Medix Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Novo Medix Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Aurobinda Banerjee Whole-Time Director 03 Jan 2020 Current
Sabir Hossain Additional Director 27 Dec 2022 Current
Khondaker Nurul Islam Additional Director 02 Aug 2021 Current
Abhijit Basu Managing Director 03 Jan 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Dec 2020 Past
Pramod Abcsdd Director 31 Dec 2020 Past
Pramod Abcsdd Director 31 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Novo Medix Pharmaceutical.

Novo Medix Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.68% decrease. The company also saw a substantial fall in profitability, with a 51.8% decrease in profit. The company's net worth Soared by an impressive increase of 83.86%.

Novo Medix Pharmaceutical revenue growth over time
Novo Medix Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -20.68%
*******
*******
*******
*******
Revenue from Operations
*******
 -20.68%
*******
*******
*******
*******
Total Assets
*******
 33.33%
*******
*******
*******
*******
Profit or Loss
*******
 -51.80%
*******
*******
*******
*******
Net Worth
*******
 83.86%
*******
*******
*******
*******
EBITDA
*******
 15732.95%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Novo Medix Pharmaceutical?

Unlock access to Novo Medix Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.40 Cr
Latest Charge Details
Date Lender Amount Status
12 Dec 2024 Others ₹4.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Novo Medix Pharmaceutical?

Novo Medix Pharmaceutical has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novo Medix Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Medix Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Novo Medix Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    The activity Novo Medix Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Novo Medix Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata Ii. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 4.00 M with Charge ID 101028710 was registered on 12 Dec 2024. was completed.

  • Director Appointment

    The activity Sabir Hossain was appointed as a Additional Director was appointed as a Additional Director on 27 Dec 2022 & has been associated with this company since 3 years 2 months . was completed.

  • Director Appointment

    Khondaker Nurul Islam was appointed as a Additional Director was appointed as a Additional Director on 02 Aug 2021 & has been associated with this company since 4 years 6 months . was recorded as a recent event.

  • Director Appointment

    Aurobinda Banerjee was appointed as a Whole-time director was appointed as a Whole-time director on 03 Jan 2020 & has been associated with this company since 6 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Novo Medix Pharmaceutical Private Limited?

The CIN of Novo Medix Pharmaceutical Private Limited is U85100WB2020PTC235666.

Where is Novo Medix Pharmaceutical Private Limited headquartered?

Novo Medix Pharmaceutical Private Limited is headquartered at 191 Debinibas Road, Ground Floor P.O - Motijheel, P.S. Dumdum, Kolkata, West Bengal, 700074.

When was Novo Medix Pharmaceutical Private Limited incorporated?

Novo Medix Pharmaceutical Private Limited was incorporated on 03 January 2020.

Who are the current directors of Novo Medix Pharmaceutical Private Limited?

The current directors of Novo Medix Pharmaceutical Private Limited are

What is the primary industry of Novo Medix Pharmaceutical Private Limited?

The primary industry of Novo Medix Pharmaceutical Private Limited is Trade.

Is Novo Medix Pharmaceutical Private Limited a listed company?

Novo Medix Pharmaceutical Private Limited is unlisted.

What is the capital structure of Novo Medix Pharmaceutical Private Limited?

The authorized capital of Novo Medix Pharmaceutical Private Limited is ₹0.60 M, and the paid-up capital is ₹0.60 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available